Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:727241.
doi: 10.1155/2011/727241. Epub 2010 Oct 26.

Targeted liposomal drug delivery to monocytes and macrophages

Ciara Kelly  1 , Caroline Jefferies, Sally-Ann Cryan
Affiliations

Targeted liposomal drug delivery to monocytes and macrophages

Ciara Kelly et al. J Drug Deliv. 2011.

Abstract

As the role of monocytes and macrophages in a range of diseases is better understood, strategies to target these cell types are of growing importance both scientifically and therapeutically. As particulate carriers, liposomes naturally target cells of the mononuclear phagocytic system (MPS), particularly macrophages. Loading drugs into liposomes can therefore offer an efficient means of drug targeting to MPS cells. Physicochemical properties including size, charge and lipid composition can have a very significant effect on the efficiency with which liposomes target MPS cells. MPS cells express a range of receptors including scavenger receptors, integrins, mannose receptors and Fc-receptors that can be targeted by the addition of ligands to liposome surfaces. These ligands include peptides, antibodies and lectins and have the advantages of increasing target specificity and avoiding the need for cationic lipids to trigger intracellular delivery. The goal for targeting monocytes/macrophages using liposomes includes not only drug delivery but also potentially a role in cell ablation and cell activation for the treatment of conditions including cancer, atherosclerosis, HIV, and chronic inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of liposomal targeting strategies to macrophages.
Figure 2
Figure 2
Uptake of neutral (DOPC : Chol 7 : 3) and anionic (DOPS : Chol 7 : 3) liposomes by differentiated THP-1 cells after 2 hours (n = 6 ± SEM) *P < .05; **P < .001.
Figure 3
Figure 3
Uptake of uncoated and mannosylated liposomes by macrophage like differentiated THP-1 cells after 2 hours [78]. (n = 6 ± SEM) *P < .05; **P < .001.
See this image and copyright information in PMC

References

    1. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nature Reviews Immunology. 2007;7(12):964–974. - PubMed
    1. Eue I. Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: participation of activated macrophages in the antitumor mechanism. International Journal of Cancer. 2001;92(3):426–433. - PubMed
    1. Eue I, Kumar R, Dong Z, Killion JJ, Fidler IJ. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes. Journal of Immunotherapy. 1998;21(5):340–351. - PubMed
    1. Killion JJ, Fidler IJ. Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators. Pharmacology and Therapeutics. 1998;78(3):141–154. - PubMed
    1. Chono S, Tanino T, Seki T, Morimoto K. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. Journal of Controlled Release. 2008;127(1):50–58. - PubMed